Induced secretion of insulin-like growth factor binding protein-1 (IGFBP-1) in human hepatoma cell HepG2 by rubratoxin B

Archives of Toxicology

Volumn 81, Issue 5, 2007, Pages 347-351

  Nagashima, Hitoshi ^a   Maeda Nakamura, Kumiko ^a   Iwashita, Keiko ^a   Goto, Tetsuhisa ^a,b  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Insulin like growth factor binding protein 1 (IGFBP 1); Rubratoxin B; Stress activated MAP kinase (SAPK)

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RUBRATOXIN B; SOMATOMEDIN BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION INITIATION;

ANTHRACENES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MYCOTOXINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 34247897080     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0162-5     Document Type: Article

References (34)

1. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686
2. Burnside JE, Sippel WL, Forgacs J, Carll WT, Atwood MB, Doll ER (1957) A disease of swine and cattle caused by eating moldy corn. II. Experimental production with pure cultures of molds. Am J Vet Res 18:817-824
3. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40
4. Conover CA, Lee PD (1990) Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells. J Clin Endocrinol Metab 70:1062-1067
5. Coppock HA, White A, Aplin JD, Westwood M (2004) Matrix metalloproteinase-3 and -9 proteolyze insulin-like growth factor-binding protein-1. Biol Reprod 71:438-443
6. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC (1995) SB 203580 is a speciWc inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233
7. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
8. Frost RA, Nystrom GJ, Lang CH (2000) Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1β: requirement of the mitogen-activated protein kinase pathway. Endocrinology 141:3156-3164
9. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111-122
10. Iwashita K, Nagashima H (2005) EVects of genetics, sex, and age on the toxicity of rubratoxin B in mice. Mycotoxins 55:35-42
11. Kordula T, Guttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L (1992) Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor β1. FEBS Lett 313:143-147
12. Kumar V, Sivis C, Nystrom G, Deshpande N, Vary TC, Frost RA, Lang CH (2002) Alcohol-induced increases in insulin-like growth factor binding protein-1 are partially mediated by TNF. Alcohol Clin Exp Res 26:1574-1583
13. Lee PD, Giudice LC, Conover CA, Powell DR (1997) Insulin-like growth factor binding protein-1: recent Wnding and new directions. Proc Soc Exp Biol Med 216:319-357
14. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC (1991) Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 129:2254-2256
15. Lotz M, Guerne P-A (1991) Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266:2017-2020
16. Moss MO, Robinson FV, Wood AB, Paisley HM, Feeney J (1968) Rubratoxin B, a proposed structure for a bis-anhydride from Penicillium rubrum Stoll. Nature 220:767-770
17. Nagashima H (1996) Cytotoxic eVects of rubratoxin B on cultured cells. Mycotoxins 42:57-61
18. Nagashima H, Goto T (1998) Rubratoxin B induces apoptosis in HL-60 cells in the presence of internucleosomal fragmentation. Mycotoxins 46:17-22
19. Nagashima H, Ishizaki Y, Nishida M, Morita I, Murota S, Goto T (1998) Rubratoxin B induces apoptosis in p53-null cells. Mycotoxins 46:35-37
20. Nagashima H, Goto T (2000) Calcium channel blockers verapamil and diltiazem impaired rubratoxin B-caused toxicity in HL60 cells. Toxicol Lett 118:47-51
21. Nagashima H, Nakamura K, Goto T (2001a) Rubratoxin B caused hypoglycemia and elevated serum interleukin-6 levels in mice. Mycotoxins 51:7-12
22. Nagashima H, Nakamura K, Goto T (2001b) Hepatotoxin rubratoxin B induced the secretion of TNF-α, IL-8, and MCP-1 in HL60 cells. Biochem Biophys Res Commun 287:829-832
23. Nagashima H, Nakamura K, Goto T (2003) Rubratoxin B induced the secretion of hepatic injury-related colony stimulating factors in human hepatoma cells. Toxicol Lett 145:153-159
24. Nagashima H, Nakamura K, Goto T (2004) Rubratoxin B induces apoptosis in human hepatoma cells. Mycotoxins 54:21-25
25. Nagashima H, Nakamura K, Goto T (2005) Stress-activated MAP kinases regulate rubratoxin B-caused cytotoxicity and cytokine secretion in hepatocyte-derived HepG2 cells. Toxicol Lett 155:259-267
26. Nagashima H, Maeda-Nakamura K, Iwashita K, Goto T (2006) Induced secretion of tissue inhibitor of metalloproteinases-1 (TIMP-1) in vivo and in vitro by hepatotoxin rubratoxin B. Food Chem Toxicol 44:1138-1143
27. Natori S, Sakaki S, Kurata H, Udagawa S, Ichinoe M, Saito M, Umeda M, Ohtsubo K (1970) Production of rubratoxin B by Penicillium purpurogenum Stoll. Appl Microbiol 19:613-617
28. Richer L, Sigalet D, Kneteman N, Shapiro J, Jones A, Scott RB, Ashbourne R, Figler L, Frisvad J, Smith L (1997) Fulminant hepatic failure following ingestion of moldy homemade rhubarb wine. Gastroenterology 112:A1366
29. Ross RJM, Rodriguez-Arnao J, Donaghy A, Bentham J, Clark A, Holly J, Williams R, Gimson A (1994) Expression of IGFBP-1 in normal and cirrhotic human livers. J Endocrinol 141:377-382
30. Samstein B, Hoimes ML, Fan J, Frost RA, Gelato MC, Lang CH (1996) IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production. Biochem Biophys Res Commun 228:611-615
31. Scharf JG, Dombrowski F, Novosyadlyy R, Eisenbach C, Demori I, Kübler B, Braulke T (2004) Insulin-like growth factor (IGF)-binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells. Endocrinology 145:3463-3472
32. Sharma KD, Nagashima H (2005) Protective eVects of Xavonoids against rubratoxin B toxicity in human hepatocellular carcinoma cells. Mycotoxins 55:101-105
33. Takenaka A, Miura Y, Mori M, Hirosawa M, Kato H, Noguchi T (1991) Distribution of messenger RNAs of insulin-like growth factor (IGF)-binding proteins-1 and -3 between parenchymal and nonparenchymal cells in rat liver. Agric Biol Chem 55:1191-1193
34. Wilson BJ, Harbison RD (1973) Rubratoxins. J Am Vet Med Assoc 163:1274-1276